The EANM guideline on radioiodine therapy of benign thyroid disease.

Alfredo CampennìAnca M AvramFrederik A VerburgIoannis IakovouHeribert HänscheidBart de KeizerPetra Petranović OvčaričekLuca Giovanella

Published in: European journal of nuclear medicine and molecular imaging (2023)

This document provides the new EANM guideline on radioiodine therapy of benign thyroid disease. Its aim is to guide nuclear medicine physicians, endocrinologists, and practitioners in the selection of patients for radioiodine therapy. Its recommendations on patients' preparation, empiric and dosimetric therapeutic approaches, applied radioiodine activity, radiation protection requirements, and patients follow-up after administration of radioiodine therapy are extensively discussed.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
primary care
prognostic factors
stem cells
radiation therapy
mesenchymal stem cells
patient reported outcomes
mass spectrometry
clinical practice
patient reported
tandem mass spectrometry
monte carlo
solid phase extraction